Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Carvacrol As a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article Publisher Pubmed



Zamanian MY1, 2 ; Kujawska M3 ; Nikbakhtzadeh M4 ; Hassanshahi A5 ; Ramezanpour S6 ; Kamiab Z7, 8 ; Bazmandegan G7, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
  2. 2. School of Nahavand Paramedical, Hamadan University of Medical Sciences, Hamadan, Iran
  3. 3. Department of Toxicology, Poznan University of Medical Sciences, Dojazd 30, Poznan, 60-631, Poland
  4. 4. Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Physiology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. 6. Shohada Hospital, Bandar Gaz, Golestan University of Medical Sciences, Bandar Gaz, Iran
  7. 7. Clinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
  8. 8. Department of Family Medicine, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsan-jan University of Medical Sciences, Rafsanjan, Iran

Source: CNS and Neurological Disorders - Drug Targets Published:2021


Abstract

Background and Objective: Neurological diseases are becoming a significant problem worldwide, with the elderly at a higher risk of being affected. Several researchers have investigated the neuroprotective effects of Carvacrol (CAR) (5-isopropyl-2-methyl phenol). This review system-atically surveys the existing literature on the impact of CAR when used as a neuroprotective agent in neurological diseases. Methods: The systematic review involved English articles published in the last ten years obtained from PubMed, Google Scholar, and Scopus databases. The following descriptors were used to search the literature: “Carvacrol” [Title] AND “neuroprotective (neuroprotection)” [Title] OR “stroke, traumatic brain injury, Alzheimer's disease, Parkinson's disease, seizure, epilepsy [Title]. Results: A total of 208 articles were retrieved during the search process, but only 20 studies met the eligibility criteria and were included for review. A total of 20 articles were identified, in which the efficacy of CAR was described in experimental models of stroke, traumatic brain injury, Parkin-son’s disease, Alzheimer’s disease, epilepsy, and seizure, through motor deficits improvements in neurochemical activity, especially antioxidant systems, reducing inflammation, oxidative stress and apoptosis as well as inhibition of TRPC1 and TRPM7. Conclusion: The data presented in this study support the beneficial impact of CAR on behavioural and neurochemical deficits. CAR benefits accrue because of its anti-apoptotic, antioxidant, and an-ti-inflammatory properties. Therefore, CAR has emerged as an alternative treatment for neurological disorders based on its properties. © 2021 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in in Vivo and in Vitro Models of Parkinson’S Disease, Neurotoxicity Research (2020)
2. Thymol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in in Vivo and in Vitro Model of Parkinson’S Disease Via Inhibiting Oxidative Stress, BMC Complementary Medicine and Therapies (2022)
3. Comparison of Intranasal and Intraperitoneal Administration of Eugenia Caryophyllata (Clove) Essential Oil on Spatial Memory, Anxiety-Like Behavior and Locomotor Activity in a Pilocarpine-Induced Status Epilepticus Rat Model, BMC Complementary Medicine and Therapies (2022)
4. Cigarette Smoke-Induced Toxicity Consequences of Intracellular Iron Dysregulation and Ferroptosis, Life Sciences (2021)
5. Change in Total Anti-Oxidant Capacity (Tac) of Tissue, a New Method for Improving Dermal Wound Healing, Scientific Journal of Kurdistan University of Medical Sciences (2019)
6. Functional Improvement and Immune-Inflammatory Cytokines Profile of Ischaemic Stroke Patients After Treatment With Boswellic Acids: A Randomized, Double-Blind, Placebo-Controlled, Pilot Trial, Inflammopharmacology (2019)
7. Investigation of Thymol Effect on Learning and Memory Impairment Induced by Intrahippocampal Injection of Amyloid Beta Peptide in High Fat Diet- Fed Rats, Metabolic Brain Disease (2017)
8. Stem Cells and Natural Agents in the Management of Neurodegenerative Diseases: A New Approach, Neurochemical Research (2023)
Experts (# of related papers)
View all Related Experts
Anahita Torkaman-Boutorabi (2)
Abbas Tafakhori (1)
Other Related Docs
9. Programmed Cell Death and Melatonin: A Comprehensive Review, Functional and Integrative Genomics (2024)
10. Pistacia Genus As a Potential Source of Neuroprotective Natural Products, Planta Medica (2019)
11. Inhibitory Effect of Thymus Vulgaris Extract on Memory Impairment Induced by Scopolamine in Rat, Asian Pacific Journal of Tropical Biomedicine (2015)
12. The Protective Roles and Molecular Mechanisms of Troxerutin (Vitamin P4) for the Treatment of Chronic Diseases: A Mechanistic Review, Current Neuropharmacology (2021)